Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096719 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324714 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL30240854 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31649022 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324738 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324778 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324781 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL29865581 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL20514675 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL10632304 | 0.98 | SMN1; SMN2 (0.33) | SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665155-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | The Trustees of Princeton University (US) | 2025-12-24 | — | — | EP | claimed |
| US-12492974-B2 | Sorbent composition for pre-analytical treatment of samples | IMMUNDIAGNOSTIK AG (DE) | 2025-12-09 | — | — | US | claimed |
| CN-118667043-A | Extraction method and application of rhodiola root polygalacturonic acid-galacturonic acid methyl ester polysaccharide and anti-fatigue functional beverage containing polysaccharide | 西南林业大学 | 2024-09-20 | — | — | CN | claimed |
| CN-118666529-A | Residue soil treatment additive and preparation method and application thereof | 北京交通大学 | 2024-09-20 | — | — | CN | claimed |
| WO-2024173616-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-22 | — | — | WO | claimed |
| US-20230000898-A1 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | GALECTIN THERAPEUTICS, INC. | 2023-01-05 | — | — | US | claimed |
| US-11413303-B2 | Methods for treatment of arthritis | GALECTIN THERAPEUTICS, INC. (US) | 2022-08-16 | — | — | US | claimed |
| EP-3840874-A1 | SORBENT COMPOSITION FOR PRE-ANALYTICAL TREATMENT OF SAMPLES | Immundiagnostik AG (DE) | 2021-06-30 | — | — | EP | claimed |
| WO-2020038954-A1 | SORBENT COMPOSITION FOR PRE-ANALYTICAL TREATMENT OF SAMPLES | IMMUNDIAGNOSTIK AG (DE) | 2020-02-27 | — | — | WO | claimed |
| CN-104822382-B9 | Galactose-branched carbohydrate compounds for the treatment of diabetic nephropathy and related diseases | 卡莱克汀医疗有限公司 | 2019-01-18 | — | — | CN | claimed |
| CN-104844727-A | Rose acidic pectic polysaccharide and preparation method and application thereof | SHANGHAI INST MATERIA MEDICA | 2015-08-19 | — | — | CN | claimed |
| CN-104822382-A | Galactose-branched carbohydrate compounds for the treatment of diabetic nephropathy and related diseases | GALECTIN THERAPEUTICS INC | 2015-08-05 | — | — | CN | claimed |
| CN-104812244-A | Method for enhancing specific immunotherapies in cancer treatment | GALECTIN THERAPEUTICS INC | 2015-07-29 | — | — | CN | claimed |
| CN-104619329-A | Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase | GALECTIN THERAPEUTICS INC | 2015-05-13 | — | — | CN | claimed |
| US-8962005-B2 | Gastric reflux resistant dosage forms | BANNER LIFE SCIENCES LLC (US) | 2015-02-24 | — | — | US | claimed |
| CN-104245717-A | Novel saccharide pharmaceutical composition for treating human diseases | GALECTIN THERAPEUTICS INC | 2014-12-24 | — | — | CN | claimed |
| CN-103945695-A | Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease | GALECTIN THERAPEUTICS INC | 2014-07-23 | — | — | CN | claimed |
| US-20140072625-A1 | Gastric Reflux Resistant Dosage Forms | BANNER PHARMACAPS INC. (US) | 2014-03-13 | — | — | US | claimed |
| CN-103554290-A | Glabrous sarcandra herb acidic polysaccharide, preparation method and application thereof | UNIV CHINA PHARMA | 2014-02-05 | — | — | CN | claimed |
| US-20100158958-A1 | GASTRIC REFLUX RESISTANT DOSAGE FORMS | BANNER PHARMACAPS INC. | 2010-06-24 | — | — | US | claimed |